Black Hawk Acquisition Corp and Vesicor Therapeutics Enter Forward Purchase Agreement with Meteora for Up to 1.35M Shares; Company To Domesticate As A Delaware Corporation And Change Name To Vesicor Therapeutics Holdings; Co To Pay Meteora Final Redemption Price Less $0.75 Per Backstop Investor Share; Vesicor Therapeutics Holdings May Sell Up To $200M Of Common Stock To Meteora Over 36 Months